Effects of kainic acid injection and cortical lesion on ornithine and aspartate aminotransferases in rat striatum.
The effects of cortical lesions and intrastriatal kainic acid injections on various striatal enzyme activities were investigated. Ornithine aminotransferase decreased concomitantly with glutamate uptake in decorticated and chronic kainic acid-treated rats. It was also decreased in acute kainic acid-lesioned striatum where glutamate uptake was unaffected. Aspartate aminotransferase, however, decreased only after acute kainic acid treatment. Results for glutamate uptake, glutamate decarboxylase, and choline acetyltransferase were in agreement with previous findings. These results suggest that ornithine may act as a precursor for glutamate in nerve terminals, although the nonspecific localization does not allow ornithine aminotransferase to be a convenient biochemical marker. The decrease in aspartate aminotransferase is thought to be due to the widespread cell degeneration after acute kainic acid. Aspartate aminotransferase activities were also found to be reduced in the frontal cortex, caudate nucleus and putamen of Huntington's disease brains.
D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects* / Q000201:enzymology; D005625:Frontal Lobe / Q000502:physiology*; D005971:Glutamates / Q000378:metabolism; D018698:Glutamic Acid; D006801:Humans; D006816:Huntington Disease / Q000201:enzymology; D007608:Kainic Acid / Q000633:toxicity*; D009115:Muridae; D009434:Neural Pathways / Q000502:physiology; D009953:Ornithine-Oxo-Acid Transaminase / Q000378:metabolism*; D010296:Parietal Lobe / Q000502:physiology*; D011759:Pyrrolidines / Q000633:toxicity*; D000637:Transaminases / Q000378:metabolism*
D005971:Glutamates; D011759:Pyrrolidines; D018698:Glutamic Acid; D000637:Transaminases; D001219:Aspartate Aminotransferases; D009953:Ornithine-Oxo-Acid Transaminase; D007608:Kainic Acid